Business Valens Q3 revenue dips 15% to $20.3M The company says its lower revenue was caused by lower bulk sales as well as the B.C. strike and OCS cyberattack Natalia Buendia CalvilloOctober 13, 2022
Business Valens to bring medical pot ‘smart kiosks’ to US shopping centers The first smart machine is expected to pop up in June 2022 Rheanna NeilApril 26, 2022
Business Valens rebounds 28 per cent, posting nearly $30M in Q1 revenue Following acquisitions and business transition, cannabis producer expects continued growth during 2022 Ryan GarnerApril 14, 2022
Business Valens enters Mexico via drug supplier to distribute CBD and succulent-based powder The Canadian firm has partnered with a subsidiary of US pharmaceutical firm Merger Group Natalia Buendia CalvilloDecember 21, 2021
Business Aurora partners with Valens to make minty seasonal products THC-infused mints and cranberry sauce vapes will be hitting shelves in select provinces this November Natalia Buendia CalvilloOctober 28, 2021
Business Valens set to acquire Citizen Stash for $54.3M The deal marks Valens's entry into Canada's dominant flower and pre-roll categories Nick LabaAugust 31, 2021
Industry update Valens enters US CBD market with purchase of Florida firm The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy Jared GnamApril 27, 2021
Canada Health Canada opens up CBD market with new hemp cultivar approvals With around a dozen new high-CBD hemp varieties approved, companies eye low-cost production and looser cannabidiol rules Jared GnamApril 21, 2021
Industry update Pot product manufacturer Valens bounces back in Q1 The Canadian cannabis extractor touts manufacturing strategy as Q1 sales jump 25% to $20M Jared GnamApril 15, 2021
Industry update Valens bullish on manufacturing strategy despite Q4 sales drop Despite an 11.6% drop in revenue, the Canadian cannabis extractor says domestic manufacturing expansion will boost sales this year Jared GnamFebruary 25, 2021